BEVACIZUMAB, CARBOPLATIN AND VINORELBINE FOR METASTATIC BREAST CANCER

被引：0
|
作者：
Papazisis, K. T. [1 ]
Vassiliadis, T. [1 ]
Kontivinis, L. [1 ]
Andreadis, C. [1 ]
Mouratidou, D. [1 ]
机构：
[1] Theagen Canc Hosp, Dept Med Oncol 3, Thessaloniki, Greece
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：73 / 73
页数：1
相关论文
共 50 条
  • [31] Review of bevacizumab in the treatment of metastatic breast cancer
    Heinemann, Volker
    EJC SUPPLEMENTS, 2008, 6 (08): : 13 - 18
  • [32] Review of bevacizumab in the treatment of metastatic breast cancer
    Heinemann, Volker
    EJC SUPPLEMENTS, 2008, 6 (04): : 13 - 18
  • [33] Safety of Bevacizumab in Patients with Metastatic Breast Cancer
    Hamilton, Erika P.
    Blackwell, Kimberly L.
    ONCOLOGY, 2011, 80 (5-6) : 314 - 325
  • [34] Paclitaxel plus bevacizumab for metastatic breast cancer
    Haines, Ian E.
    Miklos, George L. Gabor
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (15): : 1637 - 1637
  • [35] Vinorelbine metronomic plus bevacizumab as salvage therapy for patients with metastatic breast cancer (MBC): A multicenter phase II study
    Saloustros, E. S.
    Kalbakis, K.
    Vardakis, N. K.
    Kalykaki, A.
    Milaki, G.
    Rovithi, M.
    Agelaki, S.
    Saridaki, Z.
    Georgoulias, V.
    Mavroudis, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [36] A Phase II trial of doxil, carboplatin and bevacizumab in metastatic triple negative breast cancer and molecular correlates of response
    Hirshfield, Kim M.
    Lu, Shou-En
    Wong, Serena
    Tan, Antoinette
    Kirstein, Laurie
    Kearney, Thomas
    Shih, Weichung
    Ganesan, Shridar
    Toppmeyer, Deborah L.
    CANCER RESEARCH, 2015, 75
  • [37] Nab-Paclitaxel/Bevacizumab/Carboplatin Chemotherapy in First-Line Triple Negative Metastatic Breast Cancer
    Hamilton, Erika
    Kimmick, Gretchen
    Hopkins, Judith
    Marcom, P. Kelly
    Rocha, Gloria
    Welch, Renee
    Broadwater, Gloria
    Blackwell, Kimberly
    CLINICAL BREAST CANCER, 2013, 13 (06) : 416 - 420
  • [38] Toxicity and efficacy of oral vinorelbine and carboplatin compared with gemcitabine and carboplatin in metastatic NSCLC
    Sayers, I. G.
    Booth, S. C.
    Harris, J. M.
    LUNG CANCER, 2015, 87 : S25 - S25
  • [39] Epirubicin/vinorelbine as first line therapy in metastatic breast cancer
    Baldini, E
    Tibaldi, C
    Chiavacci, F
    Di Lieto, M
    Fioretto, L
    Giallombardo, A
    Taviani, R
    Ghezzi, P
    Bolognini, A
    Conte, P
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 49 (02) : 129 - 134
  • [40] Firstline-therapie with Carboplatin/Vinorelbine/Bevacizumab for metastasized adrenocortical carcinoma
    Austein, T.
    Schultens, A.
    Terzic, A.
    Badge, S.
    Schmitt, A.
    Teschner, M.
    Demme, B.
    Kerstan, H.
    ONKOLOGIE, 2011, 34 : 178 - 179
12345